Clinical Trials
at Boehringer Ingelheim

Uncovering Answers to Protect Patients' Health

Boehringer Ingelheim has a large and experienced global team managing and conducting clinical trials in many indications.

Basic Information

Boehringer Ingelheim conducts and sponsors clinical trials to establish safety and efficacy of the drugs we develop, either for use in their initial indication or in additional indications. read more

Boehringer Ingelheim Landmark Trials

In 2008, Boehringer Ingelheim presents results from large-scale, randomised, controlled landmark trials in cardiovascular, respiratory and cerebrovascular diseases. read more

  • ONTARGETONTARGET®
    This groundbreaking study programme explores therapeutic options in cardiovascular protection.
    read more
  • PRoFESSPRoFESS®
    The largest ever trial exploring therapeutic options in prevention of secondary stroke.
    read more
  • UPLIFTUPLIFT®
    UPLIFT® (Understanding Potential Long-term impacts on Function with Tiotropium) is a four-year landmark trial involving nearly 6.000 patients with COPD.
    read more
  • RE-LYRE-LY™
    This trial evaluates the long-term anticoagulant therapy with dabigatran etexilate.
    read more

Clinical Trial Results

Trial Results

Our databases for clinical trial protocol registration and result reporting.

global clinical trials website

IFPMA Clinical Trials Portal

IFPMA

Your source for clinical trials information on the web.

IFPMA clinical trials portal
back to top